Profound Medical market cap PROF
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $203.1M
- Highest close in our data
- $468.6M
- Mar 2021
Profound Medical is worth $203.1M at the close on Oct 23, 2026, at $5.56 a share.
That is up 23% over the last year and down 26% over five years.
Its highest close in our data was $468.6M in Mar 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $203.1M | $183.6M | $270.7M | −9% |
| 2025 | $222.5M | $121.4M | $230.4M | +46% |
| 2024 | $152.8M | $152.8M | $238.9M | −14% |
| 2023 | $177.3M | $165.2M | $310.3M | −22% |
| 2022 | $226.3M | $71.1M | $226.3M | −0% |
| 2021 | $226.9M | $225.3M | $468.6M | −7% |
| 2020 | $243.7M | $91.7M | $249M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Profound Medical's size, closest first, today.
| Company | Market cap |
|---|---|
| PROFProfound Medical | $203.1M |
| PDEXPro DEX | $199.3M |
| UTMDUtah Medical Products | $236.3M |
| INFUInfuSystem | $277.6M |
| EMBCEmbecta | $380.2M |
| KEQUKewaunee Scientific | $94.9M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| APTAlpha Pro Tech | $56.7M |
| NEPHNephros | $38.3M |
| Peer median | $257M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Profound Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.